According to the EUA application submitted to DCGI, Biological E in a phase-3 placebo-controlled clinical study, based on the drug regulator’s nod, has evaluated the safety and immunogenicity of Corbevax as a single-dose booster in Covid-negative adults fully vaccinated with either Covishield or Covaxin.
Biological E Seeks EUA For Corbevax As Booster In Adults Vaccinated With Covishield, Covaxin
(link to source)
